Leanne Kelly - 11 May 2021 Form 3 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role: Chief Financial Officer
Signature: /s/ David Baker, attorney-in-fact
Issuer symbol: GRI
Transactions as of: 11 May 2021
Net transactions value: $0
Form type: 3
Filing time: 18 May 2021, 16:05:49 UTC
Next filing: 18 May 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney